Form 4: Charles River Labs Executive Reports Stock Transactions

Joseph W. LaPlume, EVP at Charles River Laboratories, reports acquisition and disposal of company stock on January 31, 2025.

Summary

• On January 31, 2025, Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc., reported transactions involving the company's common stock.
• LaPlume acquired 2,738 shares of common stock at $0 following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022.
• He also disposed of 846 shares at a price of $165.57 per share.
• Following these transactions, LaPlume beneficially owns 24,413 shares of Charles River Laboratories common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of stock transactions. The acquisition due to performance goals is mildly positive, while the disposal is mildly negative, balancing each other out.

Positives

• The acquisition of shares due to performance goals being met could be seen as a positive indicator of the company's performance.

Negatives

• The disposal of 846 shares by an executive could be interpreted negatively by some investors, although it's a relatively small portion of their holdings.

Risks

• Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are subject to regulatory oversight to prevent insider trading.

Stakeholder Impact

• The stock transactions could have a minor impact on shareholder sentiment, depending on how the market interprets the executive's actions.

Key Dates